The estimated Net Worth of Kalman Fishman is at least $5.9 Миллион dollars as of 22 March 2019. Kalman Fishman owns over 173 units of Sensus Healthcare Inc stock worth over $5,474,321 and over the last 8 years Kalman sold SRTS stock worth over $425,038.
Sign up
Kalman Fishman SRTS stock SEC Form 4 insiders trading
Kalman has made over 16 trades of the Sensus Healthcare Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Kalman sold 173 units of SRTS stock worth $1,298 on 22 March 2019.
The largest trade Kalman's ever made was selling 13,019 units of Sensus Healthcare Inc stock on 18 June 2018 worth over $98,033. On average, Kalman trades about 3,958 units every 53 days since 2016. As of 22 March 2019 Kalman still owns at least 931,007 units of Sensus Healthcare Inc stock.
You can see the complete history of Kalman Fishman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Kalman Fishman's mailing address?
Kalman's mailing address filed with the SEC is 851 BROKEN SOUND PARKWAY NW STE 215, , BOCA RATON, FL, 33487.
Insiders trading at Sensus Healthcare Inc
Over the last 8 years, insiders at Sensus Healthcare Inc have traded over $8,288,024 worth of Sensus Healthcare Inc stock and bought 88,000 units worth $292,820 . The most active insiders traders include Joseph C Sardano, Stephen Brad Cohen и Anthony Benedict Petrelli. On average, Sensus Healthcare Inc executives and independent directors trade stock every 29 days with the average trade being worth of $58,482. The most recent stock trade was executed by John Heinrich on 17 May 2024, trading 20,000 units of SRTS stock currently worth $123,400.
What does Sensus Healthcare Inc do?
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
What does Sensus Healthcare Inc's logo look like?
Complete history of Kalman Fishman stock trades at Sensus Healthcare Inc
Sensus Healthcare Inc executives and stock owners
Sensus Healthcare Inc executives and other stock owners filed with the SEC include:
-
Stephen Cohen,
Co-Founder, Executive Vice President - Strategic Initiatives and Dermatology Sales -
Joseph C. Sardano,
Co-Founder, Chairman, CEO & Pres -
Joseph Sardano,
Chairman of the Board, President, Chief Executive Officer, Co-Founder -
Stephen Cohen,
Co-Founder & Exec. VP -
Michael J. Sardano,
VP, Gen. Counsel & Corp. Sec. -
Kim Golodetz,
Investor Relations -
Samuel O'Rear,
Non-Executive Independent Director -
William McCall,
Non-Executive Independent Director -
John Heinrich,
Non-Executive Independent Director -
Anthony Petrelli,
Non-Employee Director -
Hoi-Bun Suen,
Vice President of International Sales -
Michael Sardano,
Vice President, General Counsel, Director of Governance and Regulatory -
James Price,
Chief Technology Officer -
Nicolas Soro,
Chief Operating Officer -
Javier Rampolla,
Chief Financial Officer -
Dr. Clay Jefferies Cockerell,
Clinical Director & Member of Medical Advisory Board -
Dr. Mark S. Nestor,
Medical Director & Member of Medical Advisory Board -
Benson Suen,
VP of International Sales -
Yonatan Vainer,
Chief Technology Officer -
Nicolas Soro,
Chief Operating Officer -
Javier Rampolla,
Chief Financial Officer -
Kalman Fishman,
CHIEF TECHNOLOGY OFFICER -
Richard Golin,
EXECUTIVE VICE PRESIDENT -
Arthur Levine,
CHIEF FINANCIAL OFFICER -
Megan Cornish,
-
Magdalena Martinez,
CHIEF OPERATING OFFICER